AU2002342949A1 - Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other - Google Patents

Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other

Info

Publication number: AU2002342949A1
Authority: AU; Australia
Prior art keywords: valences; vaccine composition; enhanced adjuvant; adjuvant; enhanced
Prior art date: 2001-08-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002342949A

Other versions

AU2002342949B2 (en

Inventor

Alain Francon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Pasteur SA

Original Assignee

Aventis Pasteur SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-08

Filing date

2002-07-31

Publication date

2003-06-19

2001-08-08 Priority claimed from FR0110573A external-priority patent/FR2828406B1/en

2002-07-31 Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA

2003-06-19 Publication of AU2002342949A1 publication Critical patent/AU2002342949A1/en

2007-07-05 Application granted granted Critical

2007-07-05 Publication of AU2002342949B2 publication Critical patent/AU2002342949B2/en

2022-07-31 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR01/10573		2001-08-08
FR0110573A FR2828406B1 (en)	2001-08-08	2001-08-08	BIVALENT HAVI VACCINE COMPOSITION
PCT/FR2002/002770 WO2003013600A1 (en)	2001-08-08	2002-07-31	Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other

Publications (2)

Publication Number	Publication Date
AU2002342949A1 true AU2002342949A1 (en)	2003-06-19
AU2002342949B2 AU2002342949B2 (en)	2007-07-05

Family

ID=8866367

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002342949A Expired AU2002342949B2 (en)	2001-08-08	2002-07-31	Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other

Country Status (22)

Country	Link
US (1)	US7404960B2 (en)
EP (1)	EP1416958B2 (en)
JP (1)	JP4221291B2 (en)
KR (1)	KR100881703B1 (en)
CN (1)	CN1282486C (en)
AT (1)	ATE357929T1 (en)
AU (1)	AU2002342949B2 (en)
BR (1)	BRPI0211151B8 (en)
CA (1)	CA2455406C (en)
CY (1)	CY1107619T1 (en)
DE (1)	DE60219177T3 (en)
DK (1)	DK1416958T4 (en)
ES (1)	ES2284940T5 (en)
FR (1)	FR2828406B1 (en)
HU (1)	HU228216B1 (en)
IL (2)	IL159519A0 (en)
MX (1)	MXPA04001125A (en)
NZ (1)	NZ530727A (en)
PL (1)	PL215134B1 (en)
PT (1)	PT1416958E (en)
WO (1)	WO2003013600A1 (en)
ZA (1)	ZA200400022B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2738682A1 (en)	2004-04-15	2005-10-15	Eng-Hong Lee	Soft gel delivery system for treating poultry
MX2009002560A (en) *	2006-09-07	2009-03-20	Glaxosmithkline Biolog Sa	Vaccine.
KR101101901B1 (en) *	2009-01-30	2012-01-02	주식회사 리노	Kitchen shelves
ES2797504T3 (en)	2009-03-24	2020-12-02	Glaxosmithkline Biologicals Sa	Meningococcal factor H binding protein used as adjuvant
CN102526724B (en) *	2011-01-14	2015-07-22	四川大学	Aluminum hydroxide gel-polysaccharide composite immunologic adjuvant and preparation method and application thereof
FR2985663B1 (en) *	2012-01-17	2015-03-27	Sanofi Pasteur	METHOD FOR FORMULATING A VACCINE CONTAINING AT LEAST TWO ANTIGENS THAT CAN ADEQUATE ON ALUMINUM OXY HYDROXIDE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2734484B1 (en) *	1995-05-24	1997-06-27	Pasteur Merieux Serums Vacc	LIQUID VACCINE COMPOSITION AND MANUFACTURING METHOD
GB9806456D0 (en) *	1998-03-25	1998-05-27	Smithkline Beecham Biolog	Vaccine composition
EP1107787B1 (en) *	1998-08-28	2003-05-14	GlaxoSmithKline Biologicals S.A.	Salmonella typhi vaccine compositions
US6585973B1 (en) *	1998-10-29	2003-07-01	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Method for preparing solid phase conjugated vaccine
GB9909077D0 (en) *	1999-04-20	1999-06-16	Smithkline Beecham Biolog	Novel compositions

2001
- 2001-08-08 FR FR0110573A patent/FR2828406B1/en not_active Expired - Lifetime
2002
- 2002-07-31 ES ES02779603T patent/ES2284940T5/en not_active Expired - Lifetime
- 2002-07-31 BR BRPI0211151-9 patent/BRPI0211151B8/en not_active IP Right Cessation
- 2002-07-31 US US10/485,748 patent/US7404960B2/en not_active Expired - Lifetime
- 2002-07-31 CA CA2455406A patent/CA2455406C/en not_active Expired - Lifetime
- 2002-07-31 DE DE60219177T patent/DE60219177T3/en not_active Expired - Lifetime
- 2002-07-31 NZ NZ530727A patent/NZ530727A/en not_active IP Right Cessation
- 2002-07-31 PT PT02779603T patent/PT1416958E/en unknown
- 2002-07-31 IL IL15951902A patent/IL159519A0/en unknown
- 2002-07-31 WO PCT/FR2002/002770 patent/WO2003013600A1/en active IP Right Grant
- 2002-07-31 CN CNB028156455A patent/CN1282486C/en not_active Expired - Lifetime
- 2002-07-31 MX MXPA04001125A patent/MXPA04001125A/en active IP Right Grant
- 2002-07-31 AU AU2002342949A patent/AU2002342949B2/en not_active Expired
- 2002-07-31 HU HU0401182A patent/HU228216B1/en unknown
- 2002-07-31 DK DK02779603.6T patent/DK1416958T4/en active
- 2002-07-31 PL PL367904A patent/PL215134B1/en unknown
- 2002-07-31 EP EP02779603A patent/EP1416958B2/en not_active Expired - Lifetime
- 2002-07-31 AT AT02779603T patent/ATE357929T1/en active
- 2002-07-31 JP JP2003518604A patent/JP4221291B2/en not_active Expired - Lifetime
- 2002-07-31 KR KR1020047001923A patent/KR100881703B1/en active IP Right Grant
2003
- 2003-12-22 IL IL159519A patent/IL159519A/en unknown
2004
- 2004-01-05 ZA ZA200400022A patent/ZA200400022B/en unknown
2007
- 2007-04-16 CY CY20071100521T patent/CY1107619T1/en unknown

Similar Documents

Publication	Publication Date	Title
MXPA03008961A (en)	2004-02-12	Vaccine composition.
EG24742A (en)	2010-07-14	Vaccine composition.
AU2001256184A1 (en)	2001-09-24	6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
IL162266A0 (en)	2005-11-20	Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the useof the same
AU2002236159A1 (en)	2002-07-16	Immunogenic complex
AU2002319320A1 (en)	2003-05-22	Substituted isoxazoles and the use thereof as antibiotics
MXPA03004932A (en)	2003-09-10	Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors.
MXPA03007915A (en)	2003-12-04	Vaccine.
AU6600300A (en)	2001-03-13	Pneumococcal vaccines
AU2002307971A1 (en)	2003-04-10	Vaccine against the nile fever virus
MXPA03006989A (en)	2003-11-18	Modified leptin with reduced immunogenicity.
HK1049770A1 (en)	2003-05-30	Fan.
MXPA03007838A (en)	2003-12-08	Modified interferon alpha with reduced immunogenicity.
HUP0401157A3 (en)	2008-01-28	Methyl-thieno-benzodiazepine lyophilized formulation, its preparation and use
AU2002212049A1 (en)	2003-05-15	Novel silicone material, its preparation method and the use thereof
AU2002342949A1 (en)	2003-06-19	Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other
HUP0401182A3 (en)	2004-10-28	Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
AU2001261317A1 (en)	2001-11-20	Immunostimulant compositions and associated methods
MXPA03007625A (en)	2003-12-04	Modified thrombopoietin with reduced immunogenicity.
AU2002320079A1 (en)	2002-12-23	Vaccines, immunotherapeutics and methods of using the same
AU2002304165A1 (en)	2003-06-19	Polynucleotide vaccine
AU6159001A (en)	2001-11-26	Vaccines, immunotherapeutics and methods for using the same
AU2002303093A1 (en)	2002-09-12	Mycobacterial vaccines
ZA200208250B (en)	2003-05-15	Novel mycoplasma strains and the use thereof.
AUPR690601A0 (en)	2001-08-30	Toxin associated with sudden infant death syndrome, and uses thereof